A cohort study conducted by Lee, et al published in The Journal of Rheumatology revealed that the hazard of overall cancer was higher in patients aged 41-55 with gout than the control group in Korea (adjusted HR [aHR] 1.224, 95% CI 1.073-1.398).¹ Their findings are compatible with 1 study in Korea reporting that the hazard of overall cancer was higher in patients aged ≥ 20 years with gout than the control group (aHR 1.053, 95% CI 1.031-1.077, P < 0.01).².

中文翻译：

---

中年痛风患者的癌症风险：韩国的一项全国性人口研究。

Lee等人在《风湿病学杂志》上发表的一项队列研究显示，韩国 41-55 岁痛风患者的总体癌症风险高于对照组（调整后的 HR [aHR] 1.224，95% CI 1.073 -1.398）。¹他们的研究结果与韩国的一项研究一致，该研究报告称 20 岁以上痛风患者的总体癌症风险高于对照组（aHR 1.053，95% CI 1.031-1.077，P < 0.01）。² .